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atients and their families can 
be our greatest teachers. Such 
was the case with the initiation 
of the Warm Autopsy Program at the 
Dorothy P. & Richard P. Simmons 
Center for Interstitial Lung Disease 
at the University of Pittsburgh. This 
brief essay describes events that led to 
our beginning the program, which we 
believe uniquely beneﬁ  ts researchers 
whose work focuses on the quest 
to further understand idiopathic 
pulmonary ﬁ  brosis (IPF). We outline 
the lessons that we have learned in the 
hope that our experience may be useful 
for other centers that are considering a 
warm autopsy program for patients and 
their families. A detailed description of 
the regulatory and ethical issues related 
to warm autopsy is beyond the scope 
of this essay and has been previously 
reviewed [1].
    The idea for the Warm Autopsy 
Program was planted as one of our 
support group meetings was ending. 
One of the patients approached 
our clinical nurse specialist (KOL) 
privately, and said that he was “going 
to die soon” and wanted to donate his 
lungs to our program for research. He 
then said, “I don’t want others who 
get this disease to suffer like me.” We 
had been holding a support group for 
patients with IPF for about two years, 
and this patient and his wife attended 
frequently. He was a retired ﬁ  reﬁ  ghter 
who was unable to be seen in our 
clinical program because his insurance 
would not cover any medical expenses 
at our institution. His wife learned 
about our support group on the 
Internet and they actively participated. 
He had also been a trumpet player in 
a band and said that his participation 
in the band had decreased over the 
course of his illness. It was obvious that 
it was important to him to be able to 
donate his lungs to assist in ﬁ  nding a 
cure for this disease.
    Lesson One: Listen to the Patient
    The support group leader (KOL) told 
him that our research team “would be 
happy to be able to use your lungs to 
further the research in this area, but 
would have to explore exactly how this 
could be done.” We had never had 
patients wanting to donate their lungs 
before and had not even discussed this 
possibility. KOL quickly approached 
the program director (NK), who said 
“this could be very important—there is 
little information about what happens 
in the lung when patients die from 
IPF.” NK then investigated how to 
proceed. Shortly thereafter, he shared 
that he had spoken to the head of the 
tissue bank in pathology, who reported 
that a similar program had been 
initiated with patients with prostate 
cancer [2].
    Further research showed that warm 
autopsy (also known as rapid autopsy) 
programs have been around for more 
than 25 years [1]. Most of these long-
standing rapid autopsy programs 
focused on diseases such as Alzheimer 
disease and multiple sclerosis—where 
the organs are relatively inaccessible 
(they are not biopsied frequently from 
living patients), and therefore samples 
for research are rare [1]—but there 
were no programs for lung disease. 
Early work in organ transplantation 
paved the way for the ethical 
foundations of procuring organs [3]. 
The Uniform Anatomical Gift Act 
was adopted in the United States in 
the early 1970s to ensure that organ 
donation was an individual, free, and 
autonomous choice as the basis for 
donation from both living and cadaver 
sources [3]. Because international laws 
for consent for organ procurement, as 
well as attitudes toward organ donation, 
may differ in different countries and 
cultures [4], some aspect of these 
programs may be highly country- and 
culture-speciﬁ  c.
    We learned from the head of the 
tissue bank that for the lungs to be 
viable for research, they had to be 
received within six hours of death. This 
seemed reasonable until we considered 
our wide referral base. If death 
occurred in our hospital, the pathology 
technicians could obtain the lungs soon 
after the death. However, if the patient 
died at home or at an outside hospital, 
there were obvious constraints. We met 
with the supervisor of the tissue bank 
and worked out the details that would 
make the program work effectively 
(Figure 1). 
    First, patients need to make their 
wishes known in writing and share 
these wishes with their signiﬁ  cant 
other. At the time of their death, any 
written statement becomes null and 
void; as with organ donation, the 
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patient’s signiﬁ  cant other needs to 
carry out the patient’s wishes in order 
for the warm autopsy to take place. If 
the signiﬁ  cant other decides not to 
pursue the patient’s wishes, the warm 
autopsy does not occur. 
    The body also needs to arrive at 
the morgue with a consent form for 
the autopsy signed by the patient’s 
signiﬁ  cant other. This is potentially 
a logistical hurdle, depending on 
whether the body comes from within 
the hospital or from another setting. 
In a hospital setting, the consent forms 
for this limited autopsy are readily 
available. If the patient does not die 
at the hospital, however, the consent 
form may not be to hand. In this 
situation, the signiﬁ  cant other should 
write a letter reiterating the patient’s 
wishes, accompanied by the letter 
that the patient initially drafted; both 
documents need to accompany the 
body to the morgue. The warm autopsy 
cannot proceed at the morgue if there 
is no consent form with the body 
(Figure 1).
    We were also concerned about 
conducting research safely and properly 
within the institution’s guidelines. 
Initially, we learned that a review by 
our institutional review board was not 
necessary, as these reviews apply only to 
research on living humans. However, 
there is a special committee, the 
Committee for Oversight of Research 
Involving the Dead, that reviews all 
research studies involving dead humans 
or tissue from dead humans. While 
not legally required, an approval by 
the committee certiﬁ  es that all ethical 
concerns have been addressed [1]. 
    Lesson Two: Go to the People Who 
Have the Experience
    Our research team was excited about 
the possibility of obtaining lungs from 
patients who died with IPF, because 
these donations would provide 
researchers with the opportunity to 
study fresh lung tissue. As such, there 
was the potential for new insights, but it 
was also imperative that as health-care 
providers we recognized and honored 
our moral obligations to the patients 
and their families to respect the wishes 
of the recently deceased. 
    The ﬁ  rst opportunity for a warm 
autopsy took place in May 2003, 
when the team was at the American 
Thoracic Society International 
meeting in Seattle, Washington. The 
immediate reaction was to defer 
this autopsy and wait until the next 
opportunity. Fortunately, the patient’s 
wife was persistent in making sure her 
husband’s wishes were implemented. 
After several long-distance telephone 
calls and coordinated efforts of 
multiple members of the tissue bank, 
our staff, and a very supportive funeral 
director, the patient’s body was 
transferred, complete with consent, 
from his home to the morgue in 
our hospital for the warm autopsy. 
Upon completion of the warm 
autopsy procedure, the chest wall was 
reattached and the body was returned 
to the funeral director to carry out the 
patient’s burial wishes. 
    Lesson Three: Family Members Are 
Often Your Best Allies
    There are many beneﬁ  ts of the Warm 
Autopsy Program. The lungs can be 
studied by various researchers, including 
those whose work involves the airways, 
pulmonary arteries, lymph tissue, and 
individual cells. We have a team that 
looks at the gene networks in IPF by 
analyzing tissue samples from patients 
early on in their disease and pulmonary 
explants. Our ability to examine tissue 
from patients who have recently died 
may facilitate the ability to identify key 
events that led to the last deterioration. 
We share these ﬁ  ndings with the family 
once they become available.
    We believe this program strengthens 
the connection of the patients and 
the families to our Center. We also 
think that the program conveys 
the message that the team respects 
patients’ wishes and allows them to 
contribute even in their last days. 
As an example, one patient died in 
the early evening, and as his son was 
going through his paperwork early 
the next morning, he read his father’s 
request: “Please donate my lungs to 
the Simmons Center.” The son called 
us and relayed his father’s request. 
Our research protocol required that 
lungs be harvested within six hours 
of death, but we wanted very much 
to respect the father’s request. After 
a brief discussion, we identiﬁ  ed some 
research uses that were not affected 
by the time that had passed. While 
rejection of these lungs would have 
been completely justiﬁ  ed, we felt it was 
important to honor the patient’s wishes 
and to try to allow the son to carry out 
his father’s wishes. 
    Lesson Four: Respect Your 
Patient’s Last Wishes
    As our support group has grown, 
the principles of honesty and 
conﬁ  dentiality have been honored 
and are a mainstay of the meetings. 
The leader of a developing, growing 
group needs to be sensitive, ﬂ  exible, 
and spontaneous in order to detect 
the participants’ needs. Furthermore, 
the leader must promote group 
cohesion, offer structured information, 
ensure conﬁ  dentiality, and strengthen 
honesty and spontaneity, as well as 
avoid subjective judgment of patients’ 
concerns [5]. 
    Patients with IPF want to know how 
their fellow group members are doing. 
We talk openly about advance care 
planning. Because patients often ask 
about individuals who are not present 
at a support group meeting, we request 
their permission to update others at 
the beginning of each session. We 
are honest about what has happened 
to their fellow group members. For 
example, at one meeting, the patients 
were told about the generous offers of a 
few of their peers to donate their lungs 
for the new Warm Autopsy Program. 
One of the patients exclaimed, “Who 
would have ever thought you would 
want these old scarred lungs!” A sense 
of levity was brought to a potentially 
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awkward moment. In the discussion 
that followed, the patients talked about 
the practical and personal implications 
of being able to participate in this 
program.
    The patients have created a network 
of E-mail addresses and telephone 
numbers and communicate regularly 
outside the group setting we provide. 
The patients are adept and independent 
in their activities, and are also a good 
source of support to each other; they 
often visit each other if hospitalized, 
and send cards and E-mails.
    Lesson Five: Allow Space for 
Patient Leadership
    To date, we have had 12 patients 
participate in our Warm Autopsy 
Program, and we are currently analyzing 
the data obtained from this program. 
Preliminary analysis suggests that 
we are observing some fundamental 
mechanisms that could explain patient 
deterioration in IPF. Regardless of these 
results, the warm autopsy program has 
enriched our ties with our patients and 
strengthened our support group. It has 
provided us with an opportunity for 
our patients to exert their will in their 
last minutes and to feel that they may 
be making a major contribution to our 
understanding of IPF. 
    In a recent commentary in   Nature 
Medicine   [1], Pentz and colleagues 
provided ethical guidelines for warm 
autopsy programs. Interestingly, this 
commentary focused on the beneﬁ  ts 
to scientists and on the need to protect 
the patients and their families, but 
not on the role of patients and their 
families in this process. What we have 
learned from our patients is that 
participation in such a program can 
honor one of their last wishes. We 
also have learned that as health-care 
providers and scientists, we need to 
be alert to our patients’ stories for 
innovative ideas and practices that 
address their needs. We hope that 
our experience will be useful to other 
groups, as they may encounter similar 
questions raised by their patients. As 
these programs develop, it is important 
that we partner with our patients and 
their families and allow them to take a 
leadership role in the development of 
such meaningful programs.   
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